Retatrutide, an experimental diabetes drug, reduced A1C levels by 2 percent and body weight by 17 percent in a new late-stage ...

The FDA has approved the combination of nivolumab plus chemotherapy as first-line treatment for certain patients with stage III or IV classical Hodgkin lymphoma.The approval, for individuals aged 12 ...

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Frontline nivolumab plus AVD reduced risk of progression or death by 58% versus brentuximab vedotin plus AVD (PFS HR, 0.42) in advanced-stage classical Hodgkin lymphoma. CA209-8UT randomized 994 ...

Immunomodulatory approaches such as GRI-0621 (RARβγ agonist targeting iNKT activity) may support alveolar basement membrane repair and provide complementary biology for oral combination regimens.

The U.S. Food and Drug ​Administration on Friday approved Bristol ‌Myers Squibb's combination treatment for adults and ...

Sarepta Therapeutics SRPT announced plans to submit supplementary new drug applications (sNDAs) to the FDA for its two ...

Among patients with asthma who received four doses of depemokimab over 2 years, the annualized exacerbation rate was low, ...

The book will detail the thrash singer/guitarist’s life after being diagnosed with a squamous cell carcinoma at the back of his tongue in 2019 ...

Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.

The book will detail the thrash singer/guitarist’s life after being diagnosed with a squamous cell carcinoma at the back of his tongue in 2019 ...

Regional Health’s orthopedic hand surgery team, according to a March 16 Finger Lakes Times report.  She will see patients at the new RRH Geneva (N.Y.) Medical Campus, as well as at the system’s ...